SMS Opt-In & Consent (Call-to-Action)

Effective date: June 10, 2026 · Last updated: November 3, 2026

This page documents how prospective participants consent to receive text messages from clinical-research organizations using the Bond Trials prescreening platform. It is the verifiable Call-to-Action (CTA) for our A2P messaging program.

1. Program & Brand

Bond Health, Inc. (“Bond Trials”) operates an SMS prescreening service on behalf of healthcare and clinical-research organizations. Messages identify the sending research site by name and are used solely to determine a patient’s eligibility for a specific research study. This is an informational, business-to-patient program - it is never used for marketing, advertising, or promotional content.

2. How Patients Opt In

Consent is collected at the point of care, not through a public web form. A patient provides their mobile number and gives written authorization to be contacted by SMS about clinical-trial eligibility in one of the following ways:

Completing the participating clinic’s patient intake / contact authorization form (paper or electronic) during a visit, which includes an explicit SMS-consent checkbox (see the sample language in Section 3); or
Providing verbal or written authorization to a clinical research coordinator, which the coordinator records in the patient’s record.

A mobile number is entered into Bond Trials and contacted only after this explicit, affirmative consent is captured. We do not purchase, rent, or message phone numbers from third-party lists, and consent is never a condition of receiving medical care.

Double opt-in confirmation. The first text re-confirms consent before any screening questions are asked: the patient must reply YES to continue, or STOP to opt out (see Section 4). No screening questions are sent unless the patient affirmatively replies YES.

3. Sample Point-of-Consent Form

The SMS-consent disclosure below is the exact language presented to patients on the participating clinic’s patient intake / contact-authorization form (paper or electronic). It is shown exactly as presented to the patient - the SMS-consent checkbox is unchecked by default, so the patient must actively check it to opt in. SMS consent is optional and is never a condition of care or study participation. This is a blank template with no real patient information.

Riverside Research Clinic · Patient Intake & Contact Authorization · Form CA-100

Section 4 - SMS / Text Message Consent (optional)

I agree to receive automated/AI-assisted text messages from Riverside Research Clinic and its prescreening provider (Bond Health, Inc.) at the mobile number I provide below, regarding my potential eligibility for clinical research studies. Message frequency varies (up to ~4 messages per screening). Message & data rates may apply. I can reply STOP to opt out or HELP for help at any time. Consent is not a condition of treatment or study participation. See the Privacy Policy and SMS Terms.

Patient mobile number

Patient signature

Date

Initials

Shown in its default state: the SMS-consent checkbox is unchecked - the patient must actively check it and sign to opt in. Blank template, no real patient information. A number is entered into Bond Trials and messaged only after the patient has checked this box and signed; signed records are retained by the research site / clinic and available to carriers or messaging aggregators on request as proof of opt-in.

4. Sample Messages

Opt-in / first message

Hi Maria, this is Anya the automated Riverside Research Clinic study assistant. We're reaching out about a research study you may qualify for. We're enrolling adults 18 to 65 in a 6-month study of an investigational asthma medicine (3 clinic visits, paid up to $300). Want to see if it's a fit? Reply YES and we'll ask you a few quick questions by text. A coordinator can also call you at 555-010-0100. Reply STOP to opt out of texts for this study. Msg & data rates may apply.

Opt-out reply (after STOP)

You have been unsubscribed from Riverside Research Clinic research study messages. No further texts will be sent from this number. Reply START to resubscribe at any time.

Help reply (after HELP)

Riverside Research Clinic Research Studies: You’re receiving texts about a clinical research study. Reply YES to continue, STOP to unsubscribe, or email support@bondtrials.com for support. Msg & data rates may apply.

5. Keywords

Opt-in: YES, START, UNSTOP
Opt-out: STOP, STOP ALL, STOPALL, UNSUBSCRIBE, CANCEL, END, QUIT
Help: HELP, INFO

6. Message Types & Frequency

Messages include: the opt-in confirmation above, eligibility screening questions, an invitation to schedule an in-person screening visit, and study-specific follow-ups. Frequency is conversational and varies, generally up to 4 messages per active prescreening. See the SMS Terms & Conditions for full program terms.

7. Privacy & Data Use

Mobile opt-in data and consent records - including phone numbers - are never shared with, sold to, or transferred to any third party for marketing or any purpose other than providing this clinical-research messaging service. Full details are in our Privacy Policy.

8. Contact

Bond Health, Inc.

SMS support: support@bondtrials.com

Privacy questions: privacy@bondtrials.com